| Literature DB >> 2574509 |
Abstract
The antiarrhythmic properties of beta-adrenoceptor antagonists have long been recognized and, according to the Vaughan Williams classification of antiarrhythmic drugs, these drugs are regarded as a separate entity, namely class II. In this review, Ad IJzerman and Willem Soudijn focus on the nature and the molecular basis of the antiarrhythmic action of beta-adrenoceptor antagonists. Structure-activity relationship studies demonstrate that the antiarrhythmic profile of different beta-adrenoceptor antagonists is not fixed and some compounds have class I or class III properties which may be clinically relevant.Entities:
Mesh:
Substances:
Year: 1989 PMID: 2574509 DOI: 10.1016/0165-6147(89)90104-1
Source DB: PubMed Journal: Trends Pharmacol Sci ISSN: 0165-6147 Impact factor: 14.819